Introduction
Streptococcus pneumonia (S. pneumoniae) is an important pathogen causing serious illnesses such as sepsis, meningitis, and pneumonia [1] [2] [3] . This Gram-positive bacterium is one of the most common pathogens of bacterial meningitis in children younger than 2 years worldwide [4] . Pneumococcus causes 10% to 60% of meningitis cases among patients in different age groups, but the incidence is higher in adults patients than in children [5, 6] . Other pathogens [i.e. group B streptococcus, Escherichia coli, Listeria monocytogenes, Haemophilus influenzae type b (Hib), and Neisseria meningitides] account for most cases of bacterial meningitis in children younger than 2 years; however, the causes of this age pattern are not fully understood [7] [8] [9] . In recent years, despite advances in infection treatment strategies, the overall frequency of death associated with bacterial meningitis was between 19% to 37% [10, 11] . Antibiotic-resistance and treatment failure is a major concern, as 15%-30% of S. pneumoniae strains have become multidrug resistance [12] [13] [14] . Despite antibiotic treatment, some of the patients showed significant side effects including seizures, cognitive impairment, hearing loss and other deficiencies [15] .
Objective: To estimate the frequency of pneumococcal meningitis among patients with bacterial meningitis in Iran. The epidemiology of bacterial meningitis has been changed by several preventive measures introduced since the early 1990s, such as the introduction of the Hib conjugate vaccines and the pneumococcal conjugate vaccines for infants [16] . Although Hib and pneumococcal vaccines have been available for more than a decade in developed countries, they have only recently been available to children in low-income countries [17] . Iran does not yet use pneumococcal vaccinations routinely. Recommendations have been provided for the targeted use of the 23-valent pneumococcal polysaccharide vaccine and PCV13 among people with underlying medical conditions that increase their risk for contracting pneumococcal disease or experiencing complications of pneumococcal disease if infected. In USA, the incidence of pneumococcal meningitis in children aged <2 years has declined from 7.7% to 2.6% following the introduction of PCV [18] . Since the epidemiology of pneumococcus varies with time and geographic area, the local incidence of pneumococcal meningitis is useful for health care decision-makers. Therefore, this study was designed to analyze the national data of pneumococcal meningitis in Iran using a systematic review and meta-analysis according to the Preferred Reporting Items for Systematic Reviews and MetaAnalyses Statement [19] .
Materials and methods

Information sources and search strategy
A literature search of the bibliographic database, including PubMed, Embase, Web of Science and Scientific Information Database (www. sid.ir), was performed from 2000 to 2016. The search strategies were based on the following search terms: (Streptococcus pneumoniae OR S. pneumonia OR pneumococcus) AND (meningitis) AND (Iran). This combination of terms was used for searching in article title, abstract or keywords. Reference lists of selected articles (backward citation) and the relevant articles found during the initial search were searched and forward citation tracking was carried out, to identify further relevant studies. The records found through database searching were merged and the duplicates and overlap of patient population and date of the study were removed using EndNote X7 (Thomson Reuters, New York, NY, USA). The records were initially screened by title and abstract to exclude those not related to the current study. Then the full-text of potentially eligible records were retrieved and examined.
Inclusion and exclusion criteria
Studies were included if they met all of the following criteria:(1) Studies evaluating bacterial meningitis; (2) Reporting standard laboratory-confirmed bacterial meningitis (cerebrospinal fluid culture) and (3) Presenting the frequency of S. pneumoniae.
Our exclusion criteria were: (1) Data on bacterial meningitis and S. pneumoniae were not available; (2) Nonstandard methods were used for diagnosis of bacterial meningitis (e.g. clinical presentation of patients), and (3) Data were restricted to viral meningitis.
Data extraction
The following items were extracted from each article: first author, publication date, study year, place of study, study sample size, patients' age, diagnostic methods, the number and the prevalence or frequency of patients with S. pneumoniae. Any disagreements or discrepancies were resolved in consensus with a third investigator.
Quality assessment of studies
We assessed the study quality by using a checklist provided by the Joanna Briggs Institute [20] .
Statistical analysis
For each study, the overall frequency of S. pneumoniae, and the corresponding standard errors and 95% confidence intervals (95%CI) were calculated. Analyses were performed using random-effects weights. In order to estimate a pooled effect, we utilized the "metaprop" command. We used "ftt cimethod"
(score) or Freeman-Tukey transformation procedures for collecting binomial data. The between-study heterogeneity was assessed by using Cochran's Q, and the I 2 statistic and Galbraith graph. To check for publication bias, we used Egger's and Begg's tests (P<0.05 was considered indicative of statistically significant publication bias). All the analyses were conducted using Stata 14.0 (StataCorp, College Station, Texas, USA).
Results
Study selection
A total of 131 articles were found in the initial search, of which 87 records were screened by title and abstract, 31 full-text articles were reviewed, and 21 studies were included in the final analysis ( Figure 1 ). 
Study characteristics
Risk of bias assessment
Based on the quality assessment of the included studies, all studies were identified as having a low risk of bias (quality assessment score >7).
Frequency of S. pneumonia
The pooled frequency of S. pneumoniae among patients with confirmed bacterial meningitis was 25.0% (95%CI: 19.0-32.0; 
Frequency of other bacterial meningitis
Heterogeneity and bias
As it is presented in the Galbraith plot in Figure 3 , one study was seen outside the range between -2 and 2 and considered as the major source of heterogeneity. As per Begg's (P=0.1) and Egger's (P=0.7), there was no evidence of publication bias. 
Discussion
Bacterial meningitis continues to be a serious cause of death in all age groups worldwide [42, 43] . In Iran, despite the improvement of infection control and therapeutic strategies, bacterial meningitis still remains a major public health problem. Based on previous studies in Iran [44, 45] , pneumococcus is the most common bacterium isolated from patients with meningitis. In the current systematic review and meta-analysis, we show the results of 16 years of pneumococcal meningitis surveillance in Iran. Our analyses showed that the prevalence of bacterial meningitis caused by S. pneumoniae was 25.0%.
Several studies have reported on the prevalence of S. pneumoniae around the world. For example, according to studies from Pakistan, France, Kuwait and USA, the prevalence of S. pneumoniae among meningitis cases was 38.5%, 29%, 40%, and 33%, respectively [46] [47] [48] [49] . The different prevalence of S. pneumoniae in bacterial meningitis in Iran may be due to lack of an efficient vaccination program to control and prevent pneumococcal meningitis. Due to the epidemiology of pneumococcus, children and adults are the main target populations for pneumococcal vaccines [50] .
Currently, there are two types of PCV available on the global market, synflorix (PCV10) and prevnar 13 (PCV13), which is linked to carrier proteins [51, 52] . PCV10 and 13 protect against in children [51, 56] . The remarkable reduction of the incidence rate of pneumococcal meningitis among children after PCV vaccination in developed countries has been demonstrated previously, which testified the effectiveness of these vaccines [37, 38] . Different pneumococcal vaccines have been used in different countries, with the choice depending on which serotypes dominate in a particular location and the cost of the vaccines [57, 58] . The most common serotypes isolated from pneumococcal meningitis in our country were 18, 14, 19A, 6A, 7F, 4, 3, 9V, 23F and 5 [45, 56, 59] , which are covered by the 13-valent PCV [60, 61] ; hence, the use of the PCV13 for general coverage of pneumococcal meningitis infections are recommended.
The frequency of antibiotic-resistant pneumococcal strains is increasing worldwide, with some variations between different countries [62, 63] . Also, based on the results of previous studies, resistance to macrolides has been observed among pneumococcal strains isolated from children with pneumococcal meningitis [64] .
Moreover, antibiotic-resistance is more common among vaccine serotypes [51] . Hence, the use of PCVs can be the best option for both preventions of pneumococcal meningitis and for reducing the frequency of antibiotic resistance in the short term.
Neurologic abnormalities occur with increased frequency in those who have had bacterial meningitis. Thus, the causes of the death resulted from pneumococcal meningitis may be due to the neurological complications [65] . Based on the study conducted by
Kastenbauer et al, more than half of the patients had meningitisassociated intracranial complications (e.g. seizures, arterial cerebrovascular complications, brain swelling, and hydrocephalus) [66] . Furthermore, they reported that seizures, cerebrovascular complications, brain swelling, and hydrocephalus were associated with adverse outcome [66] . Østergaard et al, has also indicated that most of the patients with bacterial meningitis had neurological sequelae (i.e. neurological deficits) [65] . Likewise, in the current study, several patients developed neurological abnormalities during the clinical course of the disease (i.e. seizures developed in 74 of 334 episodes). Seizures as one of the most important neurological complications, the incidence (23%) of it was very similar to that of previous studies on pneumococcal meningitis [66, 67] .
There were some limitations to this study which should be discussed. First, as a systematic review, the existence of potential publication bias should be considered. Second, it cannot fully represent the prevalence of S. pneumoniae in bacterial meningitis in
Iran because the extent of S. pneumoniae has not yet been examined in many regions of the country. Third, being a prevalence survey, this study is unable to determine risk factors for S. pneumoniae colonization or infection. Forth, the proportion of pneumococcus with reduced penicillin susceptibility could not be analyzed because of the limited information obtained from the studied articles.
In conclusion, the high percentage of bacterial meningitis in Iran caused by pneumococcus merits further attention from health authorities, physicians, and microbiologists. The regular surveillance of meningitis infection and the deployment of an effective vaccine may help to reduce the burden of meningitis in Iran.
